CN1429622A - Radix rhodiolae double action lozenge - Google Patents

Radix rhodiolae double action lozenge Download PDF

Info

Publication number
CN1429622A
CN1429622A CN 03101266 CN03101266A CN1429622A CN 1429622 A CN1429622 A CN 1429622A CN 03101266 CN03101266 CN 03101266 CN 03101266 A CN03101266 A CN 03101266A CN 1429622 A CN1429622 A CN 1429622A
Authority
CN
China
Prior art keywords
radix rhodiolae
radix
superfine powder
raw material
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 03101266
Other languages
Chinese (zh)
Inventor
郝基荣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 03101266 priority Critical patent/CN1429622A/en
Publication of CN1429622A publication Critical patent/CN1429622A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A dual-resistant buccal lozenge for resisting anoxia and radiation, reducing blood fat, and relieving fatigue is prepared from extractor superfine particle of rhodiola rosea, superfine powder of cordyceps, sueperfine powder of American ginseng, and additive through proportinoally mixing and tabletting.

Description

The two anti-buccal tablets of Radix Rhodiolae
One, technical field
The invention belongs to the health food technology field, particularly a kind of is the two anti-buccal tablet that primary raw material is made with the Radix Rhodiolae.
Two, technical background
Radix Rhodiolae is the Crassulaceae perennial plant; it generally is grown in the higher area of height above sea level; and special product is in its nutrition of the Tang Gute in Qinghai-Tibet Qinghai Radix Rhodiolae horn of plenty more; rhodioloside wherein and glycoside unit thereof, butyl alcohol, sterol phenoloid and flavone etc. are active ingredient; have anti-hypoxia, the two anti-functions of radioprotective preferably, also have effects such as slow down aging, neuroprotective cell, prevention myocardial ischemia and enhance immunity simultaneously.Existing market only has products such as gadol beverage, Rhodiola rosea capsules and Radix Rhodiolae pill, is not the two anti-buccal tablet that raw material is made with the Radix Rhodiolae also.
Three, summary of the invention
The objective of the invention is with the Radix Rhodiolae is that raw material is developed the two anti-buccal tablets of a kind of Radix Rhodiolae.Its mouthfeel is good, and volume is little, takes with easy to carry, has the two anti-functions of anti-hypoxia, radioprotective, eliminates organism fatigue, regains one's vigor rapidly, plurality kinds of health care effects such as nourishing and fit keeping function, tonifying the lung benefit are smart, blood fat reducing and enhance immunity.
Technical scheme is being characterized as of the two anti-buccal tablets of this Radix Rhodiolae:<one 〉, prescription is Radix Rhodiolae extract (or Radix Rhodiolae superfine powder) 5%~30% by mass percentage, Cordyceps superfine powder 1.5~18%, Radix Panacis Quinquefolii superfine powder 1.5%~18%, additive 40%~95%.<two 〉, technological process is: with above-mentioned four kinds of material by the prescription mix homogeneously, again compression molding product.Radix Rhodiolae extract is to be raw material with the Radix Rhodiolae, and water or ethanol are that solvent extracts, and through the powdery object that concentrates, makes after the spray drying, it is the effective constituent that mainly contains in the Radix Rhodiolae.The Radix Rhodiolae superfine powder is to be the coarse crushing of raw material elder generation with the Radix Rhodiolae, carries out micronizing again and obtains.The present invention is if selecting the Tang Gute Radix Rhodiolae of Qinghai-Tibet Platean for use is that raw material extracts the Radix Rhodiolae extract make or the Radix Rhodiolae superfine powder (breaking cellular wall) of superfine comminution at low temperature, and then its effect is better.Because it is pollution-free, it is more special to be grown in its nutrition of high altitude localities, to the body-care better effects if.Cordyceps powder is to adopt the superfine Cordyceps fungus in Qinghai by the mycelium that modern biofermentation technique obtains, and carries out micronizing promptly again.Radix Panacis Quinquefolii powder is to very thin flour with 100% the U.S. pure tonic good merchantable brand Radix Panacis Quinquefolii micronizing.Cordyceps powder and Radix Panacis Quinquefolii powder are the materials that human body is had fine health-care effect.Additive is also referred to as implant, it have increase tablet weight with volume, absorb liquid composition in the material, fill, be beneficial to the effect of molding and adjusting taste, as mannitol, milk powder, starch, sorbitol, lactose, dextrin, microcrystalline Cellulose and calcium sulfate etc.The simple operation easily of technology of the present invention during making mixes in proportion above-mentioned raw materials, and compression molding gets final product again.
The two anti-buccal tablets of Radix Rhodiolae of the present invention have and carry and instant, and health-care effect is good, anti-hypoxia, resisting microwave radiation, elimination organism fatigue, blood fat reducing and regain one's vigor rapidly, multiple advantages such as nourishing and fit keeping function, enhancing body immunity.
Four, the specific embodiment
It is raw material that embodiment 1. Radix Rhodiolae extracts are selected Radix Rhodiolae for use, and water is a solvent, soaks 20 hours, decocts twice with 10 times of water gagings, each 2 hours, merge decocting liquid twice, vacuum concentration, carry out again spray drying get final product the powdery Radix Rhodiolae extract.Prescription is with 15 gram Radix Rhodiolae extracts, 15 gram Cordyceps powder, 40 gram sorbitol, 30 gram milk powder get final product the Radix Rhodiolaes pair anti-buccal tablets of 100 grams.
It is raw material that embodiment 2. Radix Rhodiolae extracts are selected the Tang Gute Radix Rhodiolae of Qinghai-Tibet Platean for use, ethanol with 65% is solvent, soaks 15 hours, extracts with the distillation mode, at last extracting solution is carried out vacuum concentration, carry out again spray drying get final product the powdery Radix Rhodiolae extract.Prescription is with 10 gram Radix Rhodiolae extracts, 5 gram Cordyceps superfine powder, 20 gram Radix Panacis Quinquefolii superfine powder, 30 gram mannitol, 10 gram starch, 25 gram milk powder get final product the Radix Rhodiolaes pair anti-buccal tablets of 100 grams.
It is raw material that embodiment 3. Radix Rhodiolae micronizing are selected the Tang Gute Radix Rhodiolae for use, pulverizes with the superfine comminution at low temperature machine of-20 degree, and breaking cell wall can obtain the superfine powder Radix Rhodiolae.Prescription restrains the Radix Rhodiolae superfine powder with 15,15 gram Cordyceps superfine powder, and 20 gram Radix Panacis Quinquefolii superfine powder, 25 gram mannitol, 10 gram starch, 25 restrain milk powder can make the two anti-flake products that contain of 100 gram Radix Rhodiolaes.

Claims (5)

1. the two anti-buccal tablets of Radix Rhodiolae is characterized in that: (one) Radix Rhodiolae extract (or superfine powder minces) 5%~30%, Cordyceps superfine powder 1.5%~18%, Radix Panacis Quinquefolii superfine powder 1.5%~18%, additive 40%~95%.(2) technical process is for to mix in proportion above-mentioned four kinds of raw materials, again compression molding product.
2. two anti-buccal tablet according to claim 1 is characterized in that Radix Rhodiolae extract is is the material that solvent extraction is made with the Radix Rhodiolae for the raw material water.
3. two anti-buccal tablet according to claim 1 is characterized in that Radix Rhodiolae extract is is that raw material ethanol is the material that solvent extraction is made with the Radix Rhodiolae.
4. two anti-buccal tablet according to claim 1 is characterized in that the Radix Rhodiolae superfine powder minces, and is the material that to be raw material with the Radix Rhodiolae form with state-of-the-art super micron mill micronizing in the world.
5. according to claim 1,2,3,4 described two anti-buccal tablets, it is characterized in that the Tang Gute Radix Rhodiolae that Radix Rhodiolae extract or superfine powder mince with Qinghai-Tibet Qinghai is that raw material extracts the product of making.
CN 03101266 2003-01-18 2003-01-18 Radix rhodiolae double action lozenge Pending CN1429622A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 03101266 CN1429622A (en) 2003-01-18 2003-01-18 Radix rhodiolae double action lozenge

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 03101266 CN1429622A (en) 2003-01-18 2003-01-18 Radix rhodiolae double action lozenge

Publications (1)

Publication Number Publication Date
CN1429622A true CN1429622A (en) 2003-07-16

Family

ID=4789933

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 03101266 Pending CN1429622A (en) 2003-01-18 2003-01-18 Radix rhodiolae double action lozenge

Country Status (1)

Country Link
CN (1) CN1429622A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1301666C (en) * 2004-12-09 2007-02-28 桂林莱茵生物制品有限公司 Health food capable of raising immunity and its production process
CN100384461C (en) * 2004-04-21 2008-04-30 色达县藏医院 Anoxia resisting pharmaceutical composition and its preparation method
CN102451260A (en) * 2010-10-21 2012-05-16 海南医学院 Traditional Chinese medicine composition with function of alleviating fatigue and preparation method thereof
CN103083384A (en) * 2013-01-31 2013-05-08 李耀华 Health-care fermentative cordyceps fungal powder composition and preparation technology thereof
CN104162138A (en) * 2014-08-25 2014-11-26 王秀华 Traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases and preparation method thereof
CN106177490A (en) * 2016-07-13 2016-12-07 河北省体育科学研究所 A kind of compositions, health product or medicine, its preparation method and application

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100384461C (en) * 2004-04-21 2008-04-30 色达县藏医院 Anoxia resisting pharmaceutical composition and its preparation method
CN1301666C (en) * 2004-12-09 2007-02-28 桂林莱茵生物制品有限公司 Health food capable of raising immunity and its production process
CN102451260A (en) * 2010-10-21 2012-05-16 海南医学院 Traditional Chinese medicine composition with function of alleviating fatigue and preparation method thereof
CN103083384A (en) * 2013-01-31 2013-05-08 李耀华 Health-care fermentative cordyceps fungal powder composition and preparation technology thereof
CN104162138A (en) * 2014-08-25 2014-11-26 王秀华 Traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases and preparation method thereof
CN106177490A (en) * 2016-07-13 2016-12-07 河北省体育科学研究所 A kind of compositions, health product or medicine, its preparation method and application

Similar Documents

Publication Publication Date Title
CN102138601A (en) Beauty-maintaining tea and preparation process thereof
CN105380974A (en) Production method of ginseng cell wall-breaking powder
CN107801999A (en) A kind of folium cortex eucommiae buccal tablet with vasorelaxation action
CN1526433A (en) Compound American ginseng prepn and its prepn process
CN101537034A (en) Functional health care product containing maca and preparation method thereof
CN102578321A (en) Ginkgo dark tea and method for preparing same
CN106720377A (en) A kind of preparation method of ginsenoside LBP-X Yoghourt chewable tablets
CN102697982A (en) Composition having auxiliary blood fat reducing effect and preparation method thereof
CN106578824A (en) Lucid ganoderma effervescent tablets and preparation method thereof
CN1709140A (en) Composite melissa powder and its production process
CN1429622A (en) Radix rhodiolae double action lozenge
CN101019898B (en) Crushing method and preparation of aweto
CN101342195A (en) Preparation method for traditional Chinese medicine micro powder article
CN105581206B (en) A kind of the dendrobium nobile juice beverage and its industrialized preparing process of the beauty treatment of health care stomach
CN112076266A (en) Ganoderma lucidum spore powder buccal tablet and preparation method thereof
CN104686768A (en) Sea cucumber compressed tablet candy capable of enhancing immunity with high efficiency
CN101878899A (en) Healthcare food composite and production method thereof
CN101243872A (en) Instant pleuropterus cordatus super powder and preparation thereof
CN105639282B (en) Expand root health preservation powder and its preparation process in chrysanthemum mountain
CN1133127A (en) Ginkgo leaf health care tea and production process thereof
CN100429996C (en) Antifatigue health product improving human body immunity function effectively and preparing method thereof
CN109077323A (en) A kind of Antarctic Ocean young pilose antler polysaccharide composition and preparation method thereof
CN100346806C (en) Capsule comprising Chinese caterpillar fungus, royal jelly and matrimony vine
CN104000193A (en) Health care product with functions of tonifying kidney, keeping in good health and keeping fit, and preparation method of health care product
CN101138416B (en) Ultra-fine edible rhodiola root albumen powder preparation method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication